Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating therapeutic targeting of stress factors in ovarian cancer; status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Invasive Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma | Phase 1 | Status: COMPLETED